247 related articles for article (PubMed ID: 33976552)
1. Gαi1 Promoted Proliferation, Migration and Invasion via Activating the Akt-mTOR/Erk-MAPK Signaling Pathway in Renal Cell Carcinoma.
Chen Z; Zhang Y; Wu X; Zhang J; Xu W; Shen C; Zheng B
Onco Targets Ther; 2021; 14():2941-2952. PubMed ID: 33976552
[TBL] [Abstract][Full Text] [Related]
2. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
[TBL] [Abstract][Full Text] [Related]
3. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
4. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
5. POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway.
Jia YY; Yu Y; Li HJ
J Cancer; 2021; 12(14):4183-4195. PubMed ID: 34093819
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and clinical effects of RPS20 expression in renal clear cell carcinoma.
Shen C; Chen Z; Zhang Y; Xu W; Peng R; Jiang J; Zuo W; Fan Y; Zheng B
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36484407
[TBL] [Abstract][Full Text] [Related]
7. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
8. Poria acid inhibit the growth and metastasis of renal cell carcinoma by inhibiting the PI3K/akt/NF-κb signaling pathway.
Yang H; Zhao Y; Ren B; Wu Y; Qiu Z; Cheng Y; Qiu B
Heliyon; 2024 May; 10(10):e31106. PubMed ID: 38779018
[TBL] [Abstract][Full Text] [Related]
9. Gαi1/3 mediate Netrin-1-CD146-activated signaling and angiogenesis.
Li Y; Chai JL; Shi X; Feng Y; Li JJ; Zhou LN; Cao C; Li KR
Theranostics; 2023; 13(7):2319-2336. PubMed ID: 37153740
[TBL] [Abstract][Full Text] [Related]
10. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
[TBL] [Abstract][Full Text] [Related]
11. The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma.
Zhou Y; Tong L; Chu X; Deng F; Tang J; Tang Y; Dai Y
Cell Physiol Biochem; 2017; 43(2):733-742. PubMed ID: 28950257
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract][Full Text] [Related]
13. microRNA-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation, and cell proliferation.
Liu YY; Chen MB; Cheng L; Zhang ZQ; Yu ZQ; Jiang Q; Chen G; Cao C
Oncogene; 2018 May; 37(21):2890-2902. PubMed ID: 29520106
[TBL] [Abstract][Full Text] [Related]
14. Activation of G protein coupled estrogen receptor (GPER) promotes the migration of renal cell carcinoma via the PI3K/AKT/MMP-9 signals.
Guan BZ; Yan RL; Huang JW; Li FL; Zhong YX; Chen Y; Liu FN; Hu B; Huang SB; Yin LH
Cell Adh Migr; 2018 Mar; 12(2):109-117. PubMed ID: 25588050
[TBL] [Abstract][Full Text] [Related]
15. ITPKA1 Promotes Growth, Migration and Invasion of Renal Cell Carcinoma via Activation of mTOR Signaling Pathway.
Zhu X; Xu A; Zhang Y; Huo N; Cong R; Ma L; Chu Z; Tang Z; Kang X; Xian S; Xu X
Onco Targets Ther; 2020; 13():10515-10523. PubMed ID: 33116630
[TBL] [Abstract][Full Text] [Related]
16. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
17. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-tumour activity of sorafenib in combination with pegylated resveratrol is mediated by Akt/mTOR/p70S6k-4EBP-1 and c-Raf7MEK/ERK signaling pathways.
Wang L; Wu H; Wang Y; Xu S; Yang C; Zhang T; Liu Y; Wang F; Chen W; Li J; Sun L
Heliyon; 2023 Aug; 9(8):e19154. PubMed ID: 37664741
[TBL] [Abstract][Full Text] [Related]
19. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
Jiang H; Shi QQ; Ge LY; Zhuang QF; Xue D; Xu HY; He XZ
Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
[TBL] [Abstract][Full Text] [Related]
20. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
